| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 155.81B | 164.93B | 156.73B | 158.28B | 156.66B | 143.03B |
| Gross Profit | 13.29B | 14.27B | 12.55B | 11.55B | 11.70B | 10.89B |
| EBITDA | 5.62B | 4.50B | 5.01B | 4.39B | 3.59B | 3.93B |
| Net Income | 3.60B | 3.37B | 3.38B | 2.75B | 1.72B | 2.41B |
Balance Sheet | ||||||
| Total Assets | 75.10B | 84.58B | 74.63B | 85.36B | 81.28B | 76.95B |
| Cash, Cash Equivalents and Short-Term Investments | 8.51B | 11.49B | 8.38B | 9.60B | 8.42B | 5.25B |
| Total Debt | 3.60B | 4.76B | 1.60B | 4.99B | 7.95B | 7.59B |
| Total Liabilities | 36.74B | 42.48B | 35.72B | 46.57B | 45.35B | 40.98B |
| Stockholders Equity | 37.76B | 41.38B | 38.47B | 38.31B | 35.48B | 35.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.22B | 4.16B | 5.43B | 4.01B | -3.38B |
| Operating Cash Flow | 0.00 | 4.41B | 4.33B | 5.66B | 4.07B | -3.31B |
| Investing Cash Flow | 0.00 | -3.19B | 350.00M | -202.00M | 804.00M | -320.00M |
| Financing Cash Flow | 0.00 | 959.00M | -5.81B | -4.35B | -1.72B | -670.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥43.96B | 9.09 | ― | 3.87% | 1.79% | -12.61% | |
74 Outperform | ¥73.41B | 14.44 | ― | 3.17% | 4.65% | 5.17% | |
73 Outperform | ¥51.43B | 9.79 | ― | 3.00% | 5.40% | 8.39% | |
72 Outperform | ¥35.03B | 10.26 | ― | 4.05% | 5.23% | 0.86% | |
68 Neutral | ¥99.93B | 13.31 | ― | 3.38% | 15.74% | -3.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥144.22B | 9.05 | ― | 2.42% | 8.46% | -3.62% |